Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. - Wikidata - awgldk - TriplyDB

Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides.

Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides.

http://www.wikidata.org/entity/Q34681190

about

Molecular magnetic resonance imaging in cancer Imaging radiation response in tumor and normal tissue.Application of chemical exchange saturation transfer (CEST) MRI for endogenous contrast at 7 Tesla Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches Can we develop pathology-specific MRI contrast for "MR-negative" epilepsy?Emerging methods for disease monitoring in malignant gliomas A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation Necrosis An overview of CEST MRI for non-MR physicists Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers Nuclear overhauser enhancement mediated chemical exchange saturation transfer imaging at 7 Tesla in glioblastoma patients Nuclear Overhauser Enhancement imaging of glioblastoma at 7 Tesla: region specific correlation with apparent diffusion coefficient and histology Determination of an optimally sensitive and specific chemical exchange saturation transfer MRI quantification metric in relevant biological phantoms Magnetic Resonance Imaging of Glucose Uptake and Metabolism in Patients with Head and Neck Cancer MR imaging of protein folding in vitro employing nuclear-Overhauser-mediated saturation transfer.Quantitative correlational study of microbubble-enhanced ultrasound imaging and magnetic resonance imaging of glioma and early response to radiotherapy in a rat model.Multi-parametric MRI Assessment of Tumor Response to High-Intensity Focused Ultrasound in a Rat Glioma Model.Quantitative Bayesian model-based analysis of amide proton transfer MRI.Functional imaging in adult and paediatric brain tumours.Quantitative characterization of nuclear overhauser enhancement and amide proton transfer effects in the human brain at 7 tesla A simple model for understanding the origin of the amide proton transfer MRI signal in tissue CEST: from basic principles to applications, challenges and opportunities.Imaging of endogenous exchangeable proton signals in the human brain using frequency labeled exchange transfer imaging Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T.APT-weighted and NOE-weighted image contrasts in glioma with different RF saturation powers based on magnetization transfer ratio asymmetry analyses.Chemical exchange saturation transfer MR imaging of articular cartilage glycosaminoglycans at 3 T: Accuracy of B0 Field Inhomogeneity corrections with gradient echo method.Quantification of amide proton transfer effect pre- and post-gadolinium contrast agent administration.Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications Chemical exchange saturation transfer MRI using intermolecular double-quantum coherences with multiple refocusing pulses.Observation of true and pseudo NOE signals using CEST-MRI and CEST-MRS sequences with and without lipid suppression Advantages of chemical exchange-sensitive spin-lock (CESL) over chemical exchange saturation transfer (CEST) for hydroxyl- and amine-water proton exchange studies.Molecular Imaging Using Endogenous Cellular Proteins.Imaging of amide proton transfer and nuclear Overhauser enhancement in ischemic stroke with corrections for competing effects.Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging.Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 Tesla Anatomical, functional and molecular biomarker applications of magnetic resonance neuroimaging.Simultaneous detection and separation of hyperacute intracerebral hemorrhage and cerebral ischemia using amide proton transfer MRI.Fast simulation and optimization of pulse-train chemical exchange saturation transfer (CEST) imaging.UCEPR: Ultrafast localized CEST-spectroscopy with PRESS in phantoms and in vivo

P2860

Q26782151-B446DFA8-9A56-4114-BA07-03DECE426A0E Q26798266-BD6B86FE-2D06-4BA3-AADB-69F9F3C9E325 Q26822634-060DDC9A-8CDE-4770-ACFD-34C33E7A44DE Q26865120-BDA1C8C7-4B3E-4AE0-BECC-A1021F8FE7DB Q27021387-E624D3D0-FC37-4220-A98A-EF507976CCC3 Q27023823-3645DFE3-8F9A-4491-A120-F79ED56AA1B8 Q27315120-72CC3682-DEFA-4523-9133-D24F1FFA3522 Q28072321-BACDB1DA-88A4-4105-8987-E339CBC094FD Q28075983-62E658C9-F9E4-4038-9981-4C4BEDB4FECB Q28541749-C1599140-9484-4BB0-AA27-B610CE781454 Q28544667-BA13B992-1FFB-4E1C-9FFB-5FC9EF57BCF2 Q28822188-701E18C5-C371-4A73-B92D-A6C9651AA118 Q28828741-FDB27D85-AC6B-4F27-9E40-942F69840A92 Q30354378-4EB2D627-0A45-479B-9504-B0D41755CE9C Q30377881-1D6917FB-C326-4CB8-A5D6-8DC82D328BA4 Q30383677-3606E0C2-7A4C-4FE5-ADA6-FC85170F37E8 Q30570495-8A73D919-FF8A-4D08-BE34-AB1CECDA05F7 Q30577397-F9D7934E-02BB-4D89-93C3-DADC37628480 Q30581550-C390A187-C766-4435-9144-F5E74D369B70 Q30581860-2D18B13F-A9D8-4184-B8B2-6240C62A0F62 Q30583533-968729BF-1CEE-435E-9BF3-5075D50884A5 Q30588222-AA1C8729-C3AB-4C26-A253-ED943D56A1AE Q30594301-2C906D03-B7C0-429B-A9F6-DCADDB58F04A Q30613603-5A906892-1B16-4825-9136-E48D22C8B0C0 Q30623949-0D768370-407E-4608-9AC4-BB08CCAB177D Q30676600-46B063CD-7BF7-434E-98BE-27F4CFFD2C04 Q30692021-C49B27A7-C22C-43F5-B884-AC7327E2F811 Q30715520-2E151F90-2DC1-4D57-87CB-1BFDEB2EBB2C Q30789920-412E5D78-775A-46B2-9F94-C97C883BB390 Q30815431-E6A6A1E0-6FA6-4111-B44C-3F109E60C8DC Q30848240-2BA9E476-6570-4A91-B3E6-23679F238657 Q30856242-A0D084BE-732D-4EB8-8950-DABCD9A72C76 Q30875468-941295B5-33C4-4B91-8D9B-D6BA0D31AEEB Q30882801-0D1F848E-816E-4A15-9393-90247FCC1F99 Q30887000-4746AF0E-05EC-4418-A984-0F87E0F298BC Q30907660-29C586E8-A4E8-46D8-A516-971467B7E546 Q30910766-90785F4E-65E9-4175-BAF6-8602846A2F3F Q30933892-579E1008-4EF8-41D1-986E-4D4D3A797F16 Q30960489-EB50FF13-BD49-4A51-A348-9CBD4A252359 Q30962915-241051A9-801E-4FEF-BB9C-65CD0D41102B

P2860

Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides.

http://www.wikidata.org/entity/Q34681190

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Differentiation between glioma ...... ogenous proteins and peptides.

@ast

Differentiation between glioma ...... ogenous proteins and peptides.

@en

Differentiation between glioma ...... ogenous proteins and peptides.

@nl

type

label

Differentiation between glioma ...... ogenous proteins and peptides.

@ast

Differentiation between glioma ...... ogenous proteins and peptides.

@en

Differentiation between glioma ...... ogenous proteins and peptides.

@nl

prefLabel

Differentiation between glioma ...... ogenous proteins and peptides.

@ast

Differentiation between glioma ...... ogenous proteins and peptides.

@en

Differentiation between glioma ...... ogenous proteins and peptides.

@nl

P1433

Q34681190-2D83E1F0-7384-4EEF-95EB-23A32A3FC97B

P1476

Q34681190-C94AD10D-7C3C-4A7D-879F-EA0D72BE9FDA

P2093

Q34681190-1C196785-64C5-4FF6-89FE-DC4EC431F71B

Q34681190-20D015F1-F0CA-4905-BE14-ECA12E8B728B

Q34681190-23BBC491-604F-4777-B82C-EE4090E0B69F

Q34681190-41D03CEB-CB25-4E08-B125-66EB44273478

Q34681190-4217E25C-0E6F-4CBD-B478-00C4B966885D

Q34681190-58BE0F3D-9784-4733-8970-E18638C5411D

Q34681190-5ADF2D67-7CAC-4167-922E-14E0570ED040

Q34681190-872A848E-B987-4BF6-BBE1-D6AEE99C4CA6

Q34681190-8FDE6FFD-FED1-4620-B69E-FFC4EF35E17F

Q34681190-AD7E3F7B-899A-45D9-AFF6-D0571028A8F8

P2860

Q34681190-01924826-F6A9-4612-B28D-640CB235E621

Q34681190-09A31FEC-743C-407D-B80C-267DD80FF29C

Q34681190-0E27D661-0F86-4A37-B96B-D56B7B3F1D1C

Q34681190-0FB675AC-18A9-41FF-85D3-DA959CB67251

Q34681190-1890707B-E3E9-4FFD-A914-7C7BF54F65DE

Q34681190-1AC2A5FA-3CF6-4A78-BCFA-25ED4DA42873

Q34681190-271AAC99-91EE-45A1-89CF-C2B1AF77BDFB

Q34681190-2E175165-6DB9-4679-87E0-2E504D29E2CF

Q34681190-45452112-E5B8-472A-B260-1629003B2727

Q34681190-56E6814A-E225-421D-BC35-97F4ADC1620B

P2888

Q34681190-C9FDB271-0096-4C69-96C6-064DE02B65CA

P304

Q34681190-93D391F8-9DFB-4471-BCD0-F801438BAA85

P31

Q34681190-6027B69C-AD8B-4405-AB46-9095894D2788

P356

Q34681190-906FD94F-A74A-4A98-8D0E-8210572F2B1F

P407

Q34681190-4B1042C9-403E-4C78-938F-221253E1FC06

P433

Q34681190-4EA104CA-D64F-4A23-BC0C-51A84EE4CFD0

P478

Q34681190-F60BA727-5B6A-482F-B767-44C78F1CD0AA

P50

Q34681190-4017DA3C-E84F-4977-A9FC-83CFCE039839

P577

Q34681190-61E9D8AD-A3E3-41A9-846C-D2610A1CA9EC

P5875

Q34681190-5F406229-595F-4D5C-AC2B-75A99E14C688

P698

Q34681190-7102E6EC-F733-400F-91CB-ABA8A180F379

P932

Q34681190-579A960E-A335-4BB3-A509-8CE32B637F80

P356

P1433

Nature Medicine

P1476

Differentiation between glioma ...... ogenous proteins and peptides.

@en

P2093

Bachchu Lal

http://www.w3.org/2001/XMLSchema#string

Betty Tyler

http://www.w3.org/2001/XMLSchema#string

De-Xue Fu

http://www.w3.org/2001/XMLSchema#string

Eric Ford

http://www.w3.org/2001/XMLSchema#string

Erik Tryggestad

http://www.w3.org/2001/XMLSchema#string

Jaishri Blakeley

http://www.w3.org/2001/XMLSchema#string

Jinyuan Zhou

http://www.w3.org/2001/XMLSchema#string

John Laterra

http://www.w3.org/2001/XMLSchema#string

Kun Yan

http://www.w3.org/2001/XMLSchema#string

Rachel Grossman

http://www.w3.org/2001/XMLSchema#string

P2860

Chemical exchange saturation transfer contrast agents for magnetic resonance imaging

Malignant gliomas in adults

Diffusion imaging for therapy response assessment of brain tumor

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI.

Amide proton transfer (APT) contrast for imaging of brain tumors.

Magnetic resonance image-guided proteomics of human glioblastoma multiforme.

Clinical applications of PET in brain tumors.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST).

P2888

P304

130-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.2268

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Peter C. M. van Zijl

P577

2010-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49694656

http://www.w3.org/2001/XMLSchema#string

P698

21170048

http://www.w3.org/2001/XMLSchema#string

P932

3058561

http://www.w3.org/2001/XMLSchema#string